A new method for long-lasting delivery of punicalagin to treat osteoarthritis
Official title: A novel approach to ultralong sustained delivery of punicalagin as a potential treatment for osteoarthritis
Funded at Mississippi State University · NIH-10873549 · Data updated 2026-11-12
This study is testing a new way to deliver a pomegranate compound called punicalagin directly into the joints to help people with osteoarthritis, making it easier for them to manage their condition with fewer injections.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mississippi State University NIH-funded |
| Lab location | 1 site (Mississippi State, United States) |
| Project start | June 1, 2024 |
| Project end | May 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $391,218 |
| NIH project number | 1R15AR083143-01A1 |
| Project ID | NIH-10873549 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are at high risk of developing osteoarthritis or are in the early stages of the disease.
✕Less likely to help
Patients with advanced osteoarthritis or those who do not respond to intra-articular treatments may not benefit from this research.
What this research studies
This research focuses on developing a new delivery system for punicalagin, a compound derived from pomegranate, aimed at treating osteoarthritis (OA). The approach involves creating a microparticle system that allows for sustained release of punicalagin directly into the joints, potentially reducing the need for frequent injections. Patients may receive semiannual injections to help slow the progression of OA or prevent its onset in those at high risk. The study will assess the safety and effectiveness of this innovative treatment method.
Why it matters
Potential benefit: If successful, this research could provide a disease-modifying treatment for osteoarthritis, potentially improving joint health and quality of life for patients.
How similar studies have gone: While the approach of using punicalagin as a disease-modifying agent is novel, similar drug delivery systems have shown promise in other treatments, indicating potential for success.
Where this research is happening
-
Mississippi State University
Mississippi State, United States Active
Researchers
- Principal investigator: Elder, Steven Howard — Mississippi State University
- Study coordinator: Elder, Steven Howard
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.